Literature DB >> 22006999

p53 negatively regulates the hepatoma growth factor HDGF.

Yasushi Sasaki1, Hideaki Negishi, Masashi Idogawa, Ikuko Yokota, Ryota Koyama, Masanobu Kusano, Hiromu Suzuki, Masahiro Fujita, Reo Maruyama, Minoru Toyota, Tsuyoshi Saito, Takashi Tokino.   

Abstract

Hepatoma-derived growth factor (HDGF) is a secreted heparin-binding growth factor that has been implicated in cancer development and progression. Here, we report that HDGF is a critical target for transcriptional repression by the tumor suppressor p53. Endogenous HDGF expression was decreased in cancer cells with introduction of wild-type p53, which also downregulated HDGF expression after DNA damage. In support of the likelihood that HDGF is a critical driver of cancer cell growth, addition of neutralizing HDGF antibodies to culture media was sufficient to block cell growth, migration, and invasion. Similarly, these effects were elicited by conditioned culture medium from p53-expressing cells, and they could be reversed by the addition of recombinant human HDGF. Interestingly, we found that HDGF was overexpressed also in primary gastric, breast, and lung cancer tissues harboring mutant p53 genes. Mechanistic investigations revealed that p53 repressed HDGF transcription by altering HDAC-dependent chromatin remodeling. Taken together, our results reveal a new pathway in which loss of p53 function contributes to the aggressive pathobiological potential of human cancers by elevating HDGF expression. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006999     DOI: 10.1158/0008-5472.CAN-11-1053

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion.

Authors:  Yasushi Sasaki; Ryota Koyama; Reo Maruyama; Takehiro Hirano; Miyuki Tamura; Jun Sugisaka; Hiromu Suzuki; Masashi Idogawa; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Biol Ther       Date:  2012-09-18       Impact factor: 4.742

2.  Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion.

Authors:  Maolan Li; Jun Shen; Xiangsong Wu; Bingtai Zhang; Rui Zhang; Hao Weng; Qian Ding; Zhujun Tan; Guofeng Gao; Jiasheng Mu; Jiahua Yang; Yijun Shu; Runfa Bao; Qichen Ding; Wenguang Wu; Yang Cao; Yingbin Liu
Journal:  Med Oncol       Date:  2013-04-23       Impact factor: 3.064

Review 3.  Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment.

Authors:  Sue Chin Lee; Kuan-Hung Lin; Andrea Balogh; Derek D Norman; Mitul Bavaria; Bryan Kuo; Junming Yue; Louisa Balázs; Zoltán Benyó; Gábor Tigyi
Journal:  Cell Signal       Date:  2020-11-28       Impact factor: 4.315

4.  Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.

Authors:  Li Peng; Xiu Wu Bian; Di Kang Li; Chuan Xu; Guang Ming Wang; Qing You Xia; Qing Xiong
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

5.  CRKL oncogene is downregulated by p53 through miR-200s.

Authors:  Miyuki Tamura; Yasushi Sasaki; Kenta Kobashi; Kousuke Takeda; Takafumi Nakagaki; Masashi Idogawa; Takashi Tokino
Journal:  Cancer Sci       Date:  2015-07-14       Impact factor: 6.716

Review 6.  Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.

Authors:  Hirayuki Enomoto; Hideji Nakamura; Weidong Liu; Shuhei Nishiguchi
Journal:  Int J Mol Sci       Date:  2015-06-19       Impact factor: 5.923

7.  Hepatoma-derived growth factor upregulation is correlated with prognostic factors of early-stage cervical adenocarcinoma.

Authors:  Ching-Chou Tsai; Shun-Chen Huang; Ming Hong Tai; Chan-Chao Chang Chien; Chao-Cheng Huang; Yi-Chiang Hsu
Journal:  Int J Mol Sci       Date:  2014-11-21       Impact factor: 5.923

8.  The Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14.

Authors:  Ningning Zhao; An-Sheng Zhang; Aaron M Wortham; Shall Jue; Mitchell D Knutson; Caroline A Enns
Journal:  Nutrients       Date:  2017-12-08       Impact factor: 5.717

Review 9.  Effect of the Large and Small T-Antigens of Human Polyomaviruses on Signaling Pathways.

Authors:  Ugo Moens; Andrew Macdonald
Journal:  Int J Mol Sci       Date:  2019-08-12       Impact factor: 5.923

10.  Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.

Authors:  Xiaoqing Yu; Jingsong Zhang; Rui Yang; Chun Li
Journal:  Biomed Res Int       Date:  2020-11-14       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.